tricuspid-valve-therapies-why-transcatheter-toolbox-required

The Cardiovascular Research Foundation designates this activity for a maximum of AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Documentation of awarded credit is provided for participants in exchange for completed activity evaluations. There is no registration fee for this CME activity. If you have previously registered and would like to return to the webcast, please click here.
 

FACULTY DISCLOSURES

KEY: (G/R) Grant Support/Research Contract (C/H/S) Consultant Fee/Honoraria/Speaker’s Bureau (E/S/O) Equity/Stock(s)/Options (R/I) Royalty/Intellectual Property Rights (S) Salary/Salary Support (O) Other Financial Benefit

 

Planners:
Charles Davidson, MD  (G/R) Edwards Lifesciences, Abbott Vascular (C/H/S) Edwards Lifesciences

Susheel Kodali, MD  (C/H/S) Claret Medical, Meril Lifesciences, Abbott  (O) Dura Biotech, Thubrikar Aortic Valve Inc.

 

Faculty:  
Nadira Hamid, MD - Nothing to Disclose

Robert L. Smith, MD - (G/R) Edwards Lifesciences; Abbott Vascular; Mitre Medical; (C/H/S) Edwards Lifesciences; Abbott Vascular; CryoLife Inc


Content Reviewer(s):

Gary S. Mintz, MD – Nothing to disclose
Grzegorz L. Kaluza, MD – Nothing to disclose
Donald Cutlip, MD – Nothing to disclose
Tricia Rawh - Nothing to disclose
Joe Heard, MHA – Nothing to disclose

This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted educational grant provided by Edwards Lifesciences.